Mydecine Innovations Faces Trading Restrictions
PremiumCompany AnnouncementsMydecine Innovations Faces Trading Restrictions
4M ago
Mydecine Announces Restructuring and CEO Investment
Premium
Company Announcements
Mydecine Announces Restructuring and CEO Investment
4M ago
Mydecine Corrects Financials, Affects Company Valuation
Premium
Company Announcements
Mydecine Corrects Financials, Affects Company Valuation
4M ago
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
PremiumPress ReleasesMydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
7M ago
Mydecine Innovations Group Announces Director Resignation
Premium
Press Releases
Mydecine Innovations Group Announces Director Resignation
7M ago
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
Premium
Press Releases
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
9M ago
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
PremiumPress ReleasesMydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
11M ago
Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO
Premium
Press Releases
Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO
11M ago
Mydecine Innovations Group Announces Expected U.K. Dual Listing Admission Date
Premium
Press Releases
Mydecine Innovations Group Announces Expected U.K. Dual Listing Admission Date
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100